Farms.com Home   News

Government of Canada continues to tackle food fraud

Ottawa, Ontario - Canadian laws prohibit the misrepresentation of food. Mislabelling, adulteration and substitution of food are forms of misrepresentation and may constitute food fraud. To this end, the Canadian Food Inspection Agency (CFIA) is helping ensure food is properly labelled and safe to consume, and that businesses can compete fairly in the Canadian marketplace.

The CFIA's newly published Food Fraud Annual Report: 2020 to 2021 outlines the results of its enhanced surveillance activities to test the authenticity of 5 foods: honey, fish, olive oil, other expensive oils (such as, sesame seed oil, grapeseed oil, coconut oil and others), and spices. Overall, CFIA's testing showed 4 of the 5 commodities had satisfactory results above 87% while expensive oils (other than olive oil) had 66% satisfactory results. These 5 foods were selected as they are commonly reported as products likely to be misrepresented.

In instances where the results were unsatisfactory, the CFIA took corrective or enforcement action, including products being removed from Canada, or their detention, destruction, or relabelling. The results of the CFIA's work are being used to inform future sampling and inspection strategies to better target foods that are more likely to be misrepresented.

Source : Government of Canada

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.